Latest Breaking News On - Advanced liver cancer treated - Page 1 : comparemela.com

Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update

Advanced liver cancer patient in prior Phase II study remains cancer-free 6.9 years after starting treatment with Namodenoson .

United statesMotti farbsteinAmerican society of clinical oncologyClinical development milestonesUniversity of naples federicoCollaborations pharmaceuticalsFite biopharma ltdDrug administrationTelethon institute of geneticsAmerican association of cancer researchCan fite biopharmaDrug candidateSurvival reportedAdvanced liver cancer treatedAmerican societyClinical oncology

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMotti farbsteinKiryat matalonPnina fishmanFite biopharmaClinical development highlightsSoroka medical centerExchange commissionFite biopharma ltdTrademark office granted canEuropean medicines agencyDrug administrationCompany annual report on formWall streetClinical development highlights includePsoriasis trial met primary endpoint

Can-Fite Reports 2022 Financial Results & Provides Clinical Update

PETACH TIKVA, Israel (BUSINESS WIRE) Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory

United statesPnina fishmanMotti farbsteinFite biopharmaKiryat matalonSoroka medical centerTrademark office granted canExchange commissionClinical development highlightsCompany annual report on formFite biopharma ltdEuropean medicines agencyDrug administrationCan fite biopharmaClinical development highlights includeTrial met primary endpoint